Patents Assigned to AYANDA AS
  • Publication number: 20170105992
    Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
    Type: Application
    Filed: December 27, 2016
    Publication date: April 20, 2017
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
  • Patent number: 9539205
    Abstract: The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: January 10, 2017
    Assignee: AYANDA GROUP AS
    Inventors: Ingvild Haug, Kurt Ingar Draget
  • Publication number: 20140163108
    Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
    Type: Application
    Filed: October 19, 2011
    Publication date: June 12, 2014
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
  • Publication number: 20140065192
    Abstract: The invention relates to an orally administrable, sour-tasting chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and comprises at least one physiologically acceptable acid and at least one buffering agent and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
    Type: Application
    Filed: October 6, 2011
    Publication date: March 6, 2014
    Applicant: AYANDA GROUP AS
    Inventor: Andrzej Siwek
  • Publication number: 20140005179
    Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
    Type: Application
    Filed: April 11, 2011
    Publication date: January 2, 2014
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Haug, Magnus N. Hattrem, Tore Seternes, Steinar Johan Engelsen
  • Publication number: 20130280317
    Abstract: This invention provides oral nutraceutical or pharmaceutical compositions comprising a physiologically tolerable capsule provided with a chewing or bubble gum coat (preferably a chewing gum coat) and containing a physiologically tolerable lipid.
    Type: Application
    Filed: May 13, 2011
    Publication date: October 24, 2013
    Applicant: AYANDA GROUP AS
    Inventor: Jan Erik Olsen
  • Publication number: 20130273025
    Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
  • Publication number: 20130273152
    Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
  • Publication number: 20130274280
    Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
  • Publication number: 20130217047
    Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
    Type: Application
    Filed: September 23, 2011
    Publication date: August 22, 2013
    Applicant: AYANDA BIOSYSTEMS SA
    Inventors: Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera
  • Publication number: 20110045067
    Abstract: The invention relates to soft gelatin capsules containing at least one pharmaceutical, wherein the capsule shell includes carrageenan and cold water fish gelatin or a mixture of cold fish gelatin and warm fish gelatin.
    Type: Application
    Filed: January 29, 2009
    Publication date: February 24, 2011
    Applicant: AYANDA AS
    Inventors: Ingvild Johanne Haug, Kurt Ingar Draget
  • Publication number: 20100322995
    Abstract: The invention relates to a fish food capsule, comprising a capsule casing and a liquid or suspension-like fish food product enclosed in the capsule casing, wherein a gas phase determining the buoyancy of the fish food capsule is provided in the fish food capsule, and to the use thereof, a fish food kit, and a method for producing the fish food capsule.
    Type: Application
    Filed: October 16, 2008
    Publication date: December 23, 2010
    Applicant: AYANDA GMBH & CO. KG, FALKENHAGEN
    Inventor: Jens Geselle
  • Publication number: 20100016228
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors.
    Type: Application
    Filed: June 23, 2009
    Publication date: January 21, 2010
    Applicant: Ayanda Biosystems SA
    Inventors: FABIEN GAUTIER, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
  • Patent number: 7566764
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.
    Type: Grant
    Filed: September 3, 2001
    Date of Patent: July 28, 2009
    Assignee: Ayanda Biosystems SA
    Inventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger